                               SEQUENCE LISTING

<110> MEDIMMUNE, LLC
      HUMABS BIOMED SA
 
<120> ANTI-O2 ANTIBODIES AND USES THEREOF

<130> KLEB-100-WO-PCT

<140>
<141>

<150> 62/371,402
<151> 2016-08-05

<160> 274   

<170> PatentIn version 3.5

<210> 1
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42 VH-CDR1 peptide

<400> 1
Gly Phe Thr Phe Asn Asp Ala Trp 
1               5               


<210> 2
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42 VH-CDR2 peptide

<400> 2
Ile Lys Lys Lys His Glu Gly Val Thr Thr 
1               5                   10  


<210> 3
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42 VH-CDR3 peptide

<400> 3
Thr Thr Arg Ile Val Thr Thr Asn Asp Tyr 
1               5                   10  


<210> 4
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42 VL-CDR1 peptide

<400> 4
Ser Ser Asp Val Gly Ala Tyr Asp Tyr 
1               5                   


<210> 5
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42 VL-CDR2 peptide

<400> 5
Asp Val Asn 
1           


<210> 6
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42 VL-CDR2 peptide

<400> 6
Ile Ile Tyr Asp Val Asn Glu Arg Pro 
1               5                   


<210> 7
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42 VL-CDR3 peptide

<400> 7
Cys Ser Tyr Ala Gly Gly Asp Ile Phe Val 
1               5                   10  


<210> 8
<211> 119
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42 VH polypeptide

<400> 8
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asn Asp Ala 
            20                  25                  30          


Trp Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Arg Ile Lys Lys Lys His Glu Gly Val Thr Thr Asp Tyr Pro Ala 
    50                  55                  60                  


Ser Val Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Val Tyr Leu Gln Met Gly Arg Leu Arg Ile Glu Asp Thr Ala Ile Tyr 
                85                  90                  95      


Tyr Cys Thr Thr Arg Ile Val Thr Thr Asn Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210> 9
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42 VL polypeptide

<400> 9
Gln Ser Ala Leu Thr Gln Pro Pro Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ala Tyr 
            20                  25                  30          


Asp Tyr Val Ser Trp Tyr Gln Gln Tyr Ala Gly Lys Val Pro Lys His 
        35                  40                  45              


Ile Ile Tyr Asp Val Asn Glu Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ala Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Gly 
                85                  90                  95      


Asp Ile Phe Val Phe Gly Thr Gly Thr Gln Val Thr Val Leu 
            100                 105                 110 


<210> 10
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42--FR-1-2-4-GL-VH/KPN42-FR-GL-C105A-VL (KPN42-v2016)
      VH-CDR1 peptide

<400> 10
Gly Phe Thr Phe Asn Asp Ala Trp 
1               5               


<210> 11
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42--FR-1-2-4-GL-VH/KPN42-FR-GL-C105A-VL 
      (KPN42-v2016) VH-CDR2 peptide

<400> 11
Ile Lys Lys Lys His Glu Gly Val Thr Thr 
1               5                   10  


<210> 12
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42--FR-1-2-4-GL-VH/KPN42-FR-GL-C105A-VL
      (KPN42-v2016) VH-CDR3 peptide

<400> 12
Thr Thr Arg Ile Val Thr Thr Asn Asp Tyr 
1               5                   10  


<210> 13
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42--FR-1-2-4-GL-VH/KPN42-FR-GL-C105A-VL 
      (KPN42-v2016) VL-CDR1 peptide

<400> 13
Ser Ser Asp Val Gly Ala Tyr Asp Tyr 
1               5                   


<210> 14
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42--FR-1-2-4-GL-VH/KPN42-FR-GL-C105A-VL 
      (KPN42-v2016) VL-CDR2 peptide

<400> 14
Asp Val Asn 
1           


<210> 15
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42--FR-1-2-4-GL-VH/KPN42-FR-GL-C105A-VL 
      (KPN42-v2016) VL-CDR2 peptide

<400> 15
Met Ile Tyr Asp Val Asn Lys Arg Pro 
1               5                   


<210> 16
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42--FR-1-2-4-GL-VH/KPN42-FR-GL-C105A-VL 
      (KPN42-v2016) VL-CDR3 peptide

<400> 16
Ala Ser Tyr Ala Gly Gly Asp Ile Phe Val 
1               5                   10  


<210> 17
<211> 119
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42-v2016 VH polypeptide

<400> 17
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asn Asp Ala 
            20                  25                  30          


Trp Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Ile Lys Lys Lys His Glu Gly Val Thr Thr Asp Tyr Pro Ala 
    50                  55                  60                  


Ser Val Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Val Tyr Leu Gln Met Gly Arg Leu Arg Ile Glu Asp Thr Ala Ile Tyr 
                85                  90                  95      


Tyr Cys Thr Thr Arg Ile Val Thr Thr Asn Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210> 18
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42-v2016 VL polypeptide

<400> 18
Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ala Tyr 
            20                  25                  30          


Asp Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Asn Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ser Tyr Ala Gly Gly 
                85                  90                  95      


Asp Ile Phe Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210> 19
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42-FR-GL-VH/KPN42-FR-GL-C105A-VL VH-CDR1 peptide

<400> 19
Gly Phe Thr Phe Asn Asp Ala Trp 
1               5               


<210> 20
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42-FR-GL-VH/KPN42-FR-GL-C105A-VL VH-CDR2 peptide

<400> 20
Ile Lys Lys Lys His Glu Gly Val Thr Thr 
1               5                   10  


<210> 21
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42-FR-GL-VH/KPN42-FR-GL-C105A-VL VH-CDR3 peptide

<400> 21
Thr Thr Arg Ile Val Thr Thr Asn Asp Tyr 
1               5                   10  


<210> 22
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42-FR-GL-VH/KPN42-FR-GL-C105A-VL VL-CDR1 peptide

<400> 22
Ser Ser Asp Val Gly Ala Tyr Asp Tyr 
1               5                   


<210> 23
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42-FR-GL-VH/KPN42-FR-GL-C105A-VL VL-CDR2 peptide

<400> 23
Asp Val Asn 
1           


<210> 24
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42-FR-GL-VH/KPN42-FR-GL-C105A-VL VL-CDR2 peptide

<400> 24
Met Ile Tyr Asp Val Asn Lys Arg Pro 
1               5                   


<210> 25
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42-FR-GL-VH/KPN42-FR-GL-C105A-VL VL-CDR3 peptide

<400> 25
Ala Ser Tyr Ala Gly Gly Asp Ile Phe Val 
1               5                   10  


<210> 26
<211> 119
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42-FR-GL-VH/KPN42-FR-GL-C105A-VL VH polypeptide

<400> 26
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asn Asp Ala 
            20                  25                  30          


Trp Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Ile Lys Lys Lys His Glu Gly Val Thr Thr Asp Tyr Ala Ala 
    50                  55                  60                  


Pro Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Thr Thr Arg Ile Val Thr Thr Asn Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210> 27
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42-FR-GL-VH/KPN42-FR-GL-C105A-VL VL polypeptide

<400> 27
Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ala Tyr 
            20                  25                  30          


Asp Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Asn Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ser Tyr Ala Gly Gly 
                85                  90                  95      


Asp Ile Phe Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210> 28
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS3 VH-CDR1 peptide

<400> 28
Gly Phe Ser Phe Arg Asp Tyr Gly 
1               5               


<210> 29
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS3 VH-CDR2 peptide

<400> 29
Ile Ser Tyr Asp Gly Arg Asp Gln 
1               5               


<210> 30
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS3 VH-CDR3 peptide

<400> 30
Gly Pro Phe Tyr Asn Pro Ser Leu Tyr Tyr Pro Pro 
1               5                   10          


<210> 31
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS3 VL-CDR1 peptide

<400> 31
Gln Ser Ile Ser Ser Gln 
1               5       


<210> 32
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS3 VL-CDR2 peptide

<400> 32
Asp Ala Ser 
1           


<210> 33
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS3 VL-CDR2 peptide

<400> 33
Leu Ile His Asp Ala Ser Asn Arg Asp 
1               5                   


<210> 34
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS3 VL-CDR3 peptide

<400> 34
Leu Gln Arg Asn Asn Trp Pro Pro Trp Thr 
1               5                   10  


<210> 35
<211> 119
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS3 VH polypeptide

<400> 35
Gln Gly Gln Leu Val Asp Ser Gly Gly Gly Val Val Gln Arg Gly Gly 
1               5                   10                  15      


Ser Gln Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Phe Arg Asp Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Phe Ile Ser Tyr Asp Gly Arg Asp Gln Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ile Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Ser 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Gly Pro Phe Tyr Asn Pro Ser Leu Tyr Tyr Pro Pro Trp Gly His Gly 
            100                 105                 110         


Leu Pro Val Ile Val Ser Ser 
        115                 


<210> 36
<211> 108
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS3 VL polypeptide

<400> 36
Glu Val Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Ile Ser Ser Gln 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


His Asp Ala Ser Asn Arg Asp Thr Gly Val Pro Asp Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Met Tyr Tyr Cys Leu Gln Arg Asn Asn Trp Pro Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210> 37
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN70 VH-CDR1 peptide

<400> 37
Gly Gly Ser Ile Ser Thr Tyr Tyr 
1               5               


<210> 38
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN70 VH-CDR2 peptide

<400> 38
Ile His Gln Ser Gly Thr Thr 
1               5           


<210> 39
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN70 VH-CDR3 peptide

<400> 39
Ala Arg Glu Ser Asp Asp Gly Tyr Lys Trp Asn Tyr Phe Asp Tyr 
1               5                   10                  15  


<210> 40
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN70 VL-CDR1 peptide

<400> 40
Gln Ile Val Thr Asn Tyr 
1               5       


<210> 41
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN70 VL-CDR2 peptide

<400> 41
Asp Met Ser 
1           


<210> 42
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN70 VL-CDR2 peptide

<400> 42
Leu Ile Phe Asp Met Ser Ile Arg Ala 
1               5                   


<210> 43
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN70 VL-CDR3 peptide

<400> 43
Gln His Arg Ser Asn Trp Pro Leu Phe Thr 
1               5                   10  


<210> 44
<211> 121
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN70 VH polypeptide

<400> 44
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Thr Tyr 
            20                  25                  30          


Tyr Trp Asn Trp Ile Arg Gln Ser Pro Gly Lys Glu Leu Glu Trp Ile 
        35                  40                  45              


Ala Asn Ile His Gln Ser Gly Thr Thr Tyr Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Val Ile Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Glu Ser Asp Asp Gly Tyr Lys Trp Asn Tyr Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210> 45
<211> 108
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN70 VL polypeptide

<400> 45
Glu Ile Val Leu Thr Gln Ser Pro Ala Ser Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ile Val Thr Asn Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln His Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Phe Asp Met Ser Ile Arg Ala Ala Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln His Arg Ser Asn Trp Pro Leu 
                85                  90                  95      


Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105             


<210> 46
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179 VH-CDR1 peptide

<400> 46
Gly Phe Thr Phe Asn Asn Ala Trp 
1               5               


<210> 47
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179 VH-CDR2 peptide

<400> 47
Ile Lys Arg Lys Ala Asp Gly Glu Thr Thr 
1               5                   10  


<210> 48
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179 VH-CDR3 peptide

<400> 48
Thr Thr Arg Ile Val Thr Thr Asn Asp Tyr 
1               5                   10  


<210> 49
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179 VL-CDR1 peptide

<400> 49
Ser Ser Asp Val Gly Tyr Tyr Asp Tyr 
1               5                   


<210> 50
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179 VL-CDR2 peptide

<400> 50
Asp Val Asn 
1           


<210> 51
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179 VL-CDR2 peptide

<400> 51
Met Ile Tyr Asp Val Asn Lys Arg Pro 
1               5                   


<210> 52
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179 VL-CDR3 peptide

<400> 52
Cys Ser Tyr Ala Gly Gly Asp Thr Phe Val 
1               5                   10  


<210> 53
<211> 119
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179 VH polypeptide

<400> 53
Glu Val Gln Val Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asn Asn Ala 
            20                  25                  30          


Trp Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Ile Lys Arg Lys Ala Asp Gly Glu Thr Thr Asp Tyr Pro Ala 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Val Ser Arg Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Ile Tyr Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Ala Ile Tyr 
                85                  90                  95      


Tyr Cys Thr Thr Arg Ile Val Thr Thr Asn Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210> 54
<211> 111
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179 VL polypeptide

<400> 54
Gln Ser Ala Leu Thr Gln Pro Pro Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Tyr Tyr 
            20                  25                  30          


Asp Tyr Val Ser Trp Tyr Gln Gln His His Pro Gly Lys Ala Pro Lys 
        35                  40                  45              


His Met Ile Tyr Asp Val Asn Lys Arg Pro Ser Gly Val Pro Asp Arg 
    50                  55                  60                  


Phe Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly 
                85                  90                  95      


Gly Asp Thr Phe Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110     


<210> 55
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN44 VH-CDR1 peptide

<400> 55
Gly Gly Ser Thr Ser Ser Tyr Tyr 
1               5               


<210> 56
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN44 VH-CDR2 peptide

<400> 56
Ile His His Gly Gly Thr Thr 
1               5           


<210> 57
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN44 VH-CDR3 peptide

<400> 57
Ala Arg Glu Ser Asp Asp Gly Tyr Arg Trp Asn Tyr Phe Asp Tyr 
1               5                   10                  15  


<210> 58
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN44 VL-CDR1 peptide

<400> 58
Gln Thr Ile Thr Asn Tyr 
1               5       


<210> 59
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN44 VL-CDR2 peptide

<400> 59
Asp Met Ser 
1           


<210> 60
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN44 VL-CDR2 peptide

<400> 60
Leu Ile Phe Asp Met Ser Lys Arg Ala 
1               5                   


<210> 61
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN44 VL-CDR3 peptide

<400> 61
Gln His Arg Ser Asn Trp Pro Leu Phe Thr 
1               5                   10  


<210> 62
<211> 121
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN44 VH polypeptide

<400> 62
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Thr Ser Ser Tyr 
            20                  25                  30          


Tyr Trp Asn Trp Ile Arg Gln Ala Pro Gly Lys Pro Leu Gln Trp Ile 
        35                  40                  45              


Ala Asn Ile His His Gly Gly Thr Thr Tyr Tyr Asn Pro Ser Leu Arg 
    50                  55                  60                  


Ser Arg Val Thr Met Ser Leu Asp Thr Ser Asn Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Phe Cys Ala 
                85                  90                  95      


Arg Glu Ser Asp Asp Gly Tyr Arg Trp Asn Tyr Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Val Leu Val Thr Val Ser Ser 
        115                 120     


<210> 63
<211> 108
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN44 VL polypeptide

<400> 63
Glu Ile Val Leu Thr Gln Ser Pro Ala Ser Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Asp Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Thr Ile Thr Asn Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln His Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Phe Asp Met Ser Lys Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln His Arg Ser Asn Trp Pro Leu 
                85                  90                  95      


Phe Thr Phe Gly Pro Gly Thr Asn Val Asp Ile Lys 
            100                 105             


<210> 64
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN17 VH-CDR1 peptide

<400> 64
Gly Phe Thr Phe Ser His Phe Trp 
1               5               


<210> 65
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN17 VH-CDR2 peptide

<400> 65
Ile Asp Gly Ser Val Thr Asn Leu 
1               5               


<210> 66
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN17 VH-CDR3 peptide

<400> 66
Ala Arg Asp Leu Val Gly Ile Gly Thr Pro Ala Gly Tyr Gly Met Asp 
1               5                   10                  15      


Val 
    


<210> 67
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN17 VL-CDR1 peptide

<400> 67
Gln Gly Ile Ser Thr Tyr 
1               5       


<210> 68
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN17 VL-CDR2 peptide

<400> 68
Ala Ala Ser 
1           


<210> 69
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN17 VL-CDR2 peptide

<400> 69
Leu Ile Tyr Ala Ala Ser Thr Leu Gln 
1               5                   


<210> 70
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN17 VL-CDR3 peptide

<400> 70
Gln Gln Leu Thr Ser His Leu Tyr Thr 
1               5                   


<210> 71
<211> 124
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN17 VH polypeptide

<400> 71
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser His Phe 
            20                  25                  30          


Trp Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Val Trp Val 
        35                  40                  45              


Ala Arg Ile Asp Gly Ser Val Thr Asn Leu Arg Tyr Ala Gly Ser Val 
    50                  55                  60                  


Glu Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Asp Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu Val Gly Ile Gly Thr Pro Ala Gly Tyr Gly Met Asp 
            100                 105                 110         


Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210> 72
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN17 VL polypeptide

<400> 72
Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Thr Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Asn Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Leu Thr Ser His Leu Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210> 73
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      6F6 VH-CDR1 peptide

<400> 73
Pro Ile Ala Tyr Met Gly 
1               5       


<210> 74
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      6F6 VH-CDR2 peptide

<400> 74
Asp Ile Leu Pro Asn Ile Gly Arg Thr Ile Tyr Gly Glu Lys Phe Glu 
1               5                   10                  15      


Asp 
    


<210> 75
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      6F6 VH-CDR3 peptide

<400> 75
Arg Gly Thr Ser Gly Ala Met Asp Tyr 
1               5                   


<210> 76
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      6F6 VL-CDR1 peptide

<400> 76
Arg Ser Ser Gln Gly Leu Val His Ser Thr Gly Asn Thr Phe Leu His 
1               5                   10                  15      


<210> 77
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      6F6 VL-CDR2 peptide

<400> 77
Lys Val Ser Asn Arg Phe Ser 
1               5           


<210> 78
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      6F6 VL-CDR3 peptide

<400> 78
Ser Gln Ser Thr His Ile Pro Tyr Thr 
1               5                   


<210> 79

<400> 79
000


<210> 80
<211> 119
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      6F6 VH polypeptide

<400> 80
Gln Val His Leu Gln Gln Ser Gly Ser Glu Leu Arg Ser Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Leu Ser Cys Lys Asp Phe Asp Ser Asp Val Phe Pro Ile 
            20                  25                  30          


Ala Tyr Met Gly Trp Ile Arg Gln Gln Pro Gly His Gly Phe Asp Trp 
        35                  40                  45              


Ile Gly Asp Ile Leu Pro Asn Ile Gly Arg Thr Ile Tyr Gly Glu Lys 
    50                  55                  60                  


Phe Glu Asp Lys Ala Thr Leu Asp Ala Asp Thr Val Ser Asn Thr Ala 
65                  70                  75                  80  


Tyr Leu Glu Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Ile Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Arg Gly Thr Ser Gly Ala Met Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Ser Val Thr Val Ser Ser 
        115                 


<210> 81
<211> 112
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      6F6 VL polypeptide

<400> 81
Asp Val Val Met Thr Gln Thr Pro Leu Phe Leu Pro Val Ser Leu Gly 
1               5                   10                  15      


Asp Gln Ala Ser Ile Ser Cys Arg Ser Ser Gln Gly Leu Val His Ser 
            20                  25                  30          


Thr Gly Asn Thr Phe Leu His Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Lys Leu Leu Ile Tyr Lys Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Leu Gly Ile Tyr Phe Cys Ser Gln Ser 
                85                  90                  95      


Thr His Ile Pro Tyr Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


<210> 82
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL26 VH-CDR1 peptide

<400> 82
Gly Phe Ile Phe Gly Ser Ser Trp 
1               5               


<210> 83
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL26 VH-CDR2 peptide

<400> 83
Ile Asn Pro Asp Gly Ser Ala Thr 
1               5               


<210> 84
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL26 VH-CDR3 peptide

<400> 84
Thr Arg Asn Lys Ala Tyr Asn Ala Leu Asp Tyr 
1               5                   10      


<210> 85
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL26 VL-CDR1 peptide

<400> 85
Ser Ser Asp Val Gly Gly Asn Asn Tyr 
1               5                   


<210> 86
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL26 VL-CDR2 peptide

<400> 86
Glu Val Ser 
1           


<210> 87
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL26 VL-CDR2 peptide

<400> 87
Ile Ile Tyr Glu Val Ser Lys Arg Pro 
1               5                   


<210> 88
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL26 VL-CDR3 peptide

<400> 88
Ser Ser Phe Gly Gly Ser Lys Met 
1               5               


<210> 89
<211> 118
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL26 VH polypeptide

<400> 89
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Ser Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Glu Thr Ser Gly Phe Ile Phe Gly Ser Ser 
            20                  25                  30          


Trp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Thr Ile Asn Pro Asp Gly Ser Ala Thr Ser Tyr Glu Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Ala Val Ser Arg Asp Asn Ala Lys Asn Ser Val Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Phe Cys 
                85                  90                  95      


Thr Arg Asn Lys Ala Tyr Asn Ala Leu Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210> 90
<211> 108
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL26 VL polypeptide

<400> 90
Gln Ser Ala Leu Thr Gln Pro Pro Ser Ala Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Leu Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Asn 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Ile Ile Tyr Glu Val Ser Lys Arg Pro Ser Gly Val Pro Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Val Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Phe Gly Gly Ser 
                85                  90                  95      


Lys Met Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210> 91
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS18 VH-CDR1 peptide

<400> 91
Gly Phe Thr Phe Lys Asn Ala Trp 
1               5               


<210> 92
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS18 VH-CDR2 peptide

<400> 92
Val Lys Asn Glu Val Asp Gly Gly Thr Ile 
1               5                   10  


<210> 93
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS18 VH-CDR3 peptide

<400> 93
Arg Ala Phe Trp Ser Gly Phe Pro Ala Gly Tyr 
1               5                   10      


<210> 94
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS18 VL-CDR1 peptide

<400> 94
Arg Ser Asn Ile Gly Ser Asp Ser 
1               5               


<210> 95
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS18 VL-CDR2 peptide

<400> 95
Asp Asn Asn 
1           


<210> 96
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS18 VL-CDR2 peptide

<400> 96
Leu Met Tyr Asp Asn Asn Lys Arg Pro 
1               5                   


<210> 97
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS18 VL-CDR3 peptide

<400> 97
Ala Thr Trp Asp Ser Ser Leu Ser Ala Tyr Val 
1               5                   10      


<210> 98
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS18 VH polypeptide

<400> 98
Glu Val Arg Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Lys Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Val Lys Asn Glu Val Asp Gly Gly Thr Ile Asp Tyr Gly Val 
    50                  55                  60                  


Pro Val Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Gln Gly Thr 
65                  70                  75                  80  


Leu Ser Leu Glu Met Asn Ser Leu Arg Glu Asp Asp Thr Gly Ile Tyr 
                85                  90                  95      


Tyr Cys Arg Ala Phe Trp Ser Gly Phe Pro Ala Gly Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Ser Val Ser Ser 
        115                 120 


<210> 99
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS18 VL polypeptide

<400> 99
Gln Ser Val Leu Thr Gln Pro Pro Ser Leu Ser Ala Ala Pro Gly Gln 
1               5                   10                  15      


Thr Val Thr Ile Ala Cys Ser Gly Ser Arg Ser Asn Ile Gly Ser Asp 
            20                  25                  30          


Ser Val Ser Trp Phe Gln Gln Phe Pro Gly Thr Ala Pro Arg Val Leu 
        35                  40                  45              


Met Tyr Asp Asn Asn Lys Arg Pro Ser Gly Ile Ser Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Val Thr Leu Asp Ile Thr Gly Leu Gln 
65                  70                  75                  80  


Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Trp Asp Ser Ser Leu 
                85                  90                  95      


Ser Ala Tyr Val Phe Gly Ser Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210> 100
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS24 VH-CDR1 peptide

<400> 100
Gly Phe Thr Phe Lys Asn Ala Trp 
1               5               


<210> 101
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS24 VH-CDR2 peptide

<400> 101
Val Lys Ser Glu Val Asp Gly Gly Thr Thr 
1               5                   10  


<210> 102
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS24 VH-CDR3 peptide

<400> 102
Arg Ala Phe Trp Ser Asp Phe Gln Thr Gly Tyr 
1               5                   10      


<210> 103
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS24 VL-CDR1 peptide

<400> 103
Ser Ser Asn Ile Gly Ser Asp Ser 
1               5               


<210> 104
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS24 VL-CDR2 peptide

<400> 104
Glu Asn Asn 
1           


<210> 105
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS24 VL-CDR2 peptide

<400> 105
Leu Met Tyr Glu Asn Asn Lys Arg Pro 
1               5                   


<210> 106
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS24 VL-CDR3 peptide

<400> 106
Ala Ala Trp Asp Ser Ser Leu Arg Ala Tyr Val 
1               5                   10      


<210> 107
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS24 VH polypeptide

<400> 107
Glu Leu His Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Lys Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Val Lys Ser Glu Val Asp Gly Gly Thr Thr Asp Tyr Gly Val 
    50                  55                  60                  


Pro Val Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Gln Ser Thr 
65                  70                  75                  80  


Leu Ser Leu Glu Met Ser Ser Leu Gln Asp Asp Asp Thr Gly Val Tyr 
                85                  90                  95      


Tyr Cys Arg Ala Phe Trp Ser Asp Phe Gln Thr Gly Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210> 108
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS24 VL polypeptide

<400> 108
Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Ala Ala Pro Gly Gln 
1               5                   10                  15      


Thr Val Thr Ile Ala Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asp 
            20                  25                  30          


Ser Val Ser Trp Phe Gln Gln Leu Pro Gly Thr Ala Pro Arg Val Leu 
        35                  40                  45              


Met Tyr Glu Asn Asn Lys Arg Pro Ser Gly Ile Ser Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Val Thr Leu Gly Ile Thr Gly Leu Gln 
65                  70                  75                  80  


Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Ser Ser Leu 
                85                  90                  95      


Arg Ala Tyr Val Phe Gly Ser Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210> 109
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44 VH-CDR1 peptide

<400> 109
Gly Phe Thr Phe Lys Asn Ala Trp 
1               5               


<210> 110
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44 VH-CDR2 peptide

<400> 110
Val Lys Ser Glu Val Asp Gly Gly Thr Ile 
1               5                   10  


<210> 111
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44 VH-CDR3 peptide

<400> 111
Arg Ala Phe Trp Ser Gly Phe Pro Thr Gly Tyr 
1               5                   10      


<210> 112
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44 VL-CDR1 peptide

<400> 112
Ser Ser Asn Ile Gly Ser Asp Ser 
1               5               


<210> 113
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44 VL-CDR2 peptide

<400> 113
Glu Asn Asn 
1           


<210> 114
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44 VL-CDR2 peptide

<400> 114
Leu Ile Tyr Glu Asn Asn Lys Arg Pro 
1               5                   


<210> 115
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44 VL-CDR3 peptide

<400> 115
Ala Thr Trp Asp Ser Ser Leu Ser Ala Tyr Val 
1               5                   10      


<210> 116
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44/KPS44-G1 VH polypeptide

<400> 116
Glu Val His Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Lys Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Val Lys Ser Glu Val Asp Gly Gly Thr Ile Asp Tyr Gly Val 
    50                  55                  60                  


Pro Val Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Gln Gly Thr 
65                  70                  75                  80  


Leu Ser Leu Glu Met Asn Ser Leu Lys Asp Asp Asp Thr Gly Val Tyr 
                85                  90                  95      


Tyr Cys Arg Ala Phe Trp Ser Gly Phe Pro Thr Gly Tyr Trp Gly Gln 
            100                 105                 110         


Gly Ala Leu Val Ser Val Ser Ser 
        115                 120 


<210> 117
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44 VL polypeptide

<400> 117
Gln Ser Val Leu Thr Gln Pro Pro Ser Leu Ser Ala Ala Pro Gly Gln 
1               5                   10                  15      


Thr Ile Thr Ile Ala Cys Ser Gly Thr Ser Ser Asn Ile Gly Ser Asp 
            20                  25                  30          


Ser Val Ser Trp Phe Gln Gln Phe Pro Gly Thr Ala Pro Arg Val Leu 
        35                  40                  45              


Ile Tyr Glu Asn Asn Lys Arg Pro Ser Gly Ile Ser Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Val Thr Leu Gly Ile Thr Gly Leu Gln 
65                  70                  75                  80  


Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Trp Asp Ser Ser Leu 
                85                  90                  95      


Ser Ala Tyr Val Phe Gly Ser Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210> 118
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS30 VH-CDR1 peptide

<400> 118
Gly Phe Ser Phe Ser Thr Ser Trp 
1               5               


<210> 119
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS30 VH-CDR2 peptide

<400> 119
Ile Asp Pro Asp Gly Ser Thr Arg 
1               5               


<210> 120
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS30 VH-CDR3 peptide

<400> 120
Ala Arg Asp Tyr Ala Tyr Asn Arg Phe Asp Tyr 
1               5                   10      


<210> 121
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS30 VL-CDR1 peptide

<400> 121
Ser Ser Asp Ile Gly Ala Asn Asn Tyr 
1               5                   


<210> 122
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS30 VL-CDR2 peptide

<400> 122
Glu Val Asn 
1           


<210> 123
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS30 VL-CDR2 peptide

<400> 123
Leu Leu Tyr Glu Val Asn Lys Arg Pro 
1               5                   


<210> 124
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS30 VL-CDR3 peptide

<400> 124
Cys Gly Tyr Gly Gly Gly Arg Val 
1               5               


<210> 125
<211> 118
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS30 VH polypeptide

<400> 125
Glu Met Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Val 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Asp Ser Gly Phe Ser Phe Ser Thr Ser 
            20                  25                  30          


Trp Leu Ala Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Leu 
        35                  40                  45              


Ala Asn Ile Asp Pro Asp Gly Ser Thr Arg Asn His Val Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Tyr Ala Tyr Asn Arg Phe Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Met Val Thr Val Ser Ser 
        115             


<210> 126
<211> 108
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS30 VL polypeptide

<400> 126
Gln Ser Ala Leu Thr Gln Pro Pro Ser Ala Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Val Ile Ser Cys Thr Gly Thr Ser Ser Asp Ile Gly Ala Asn 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Leu Leu Tyr Glu Val Asn Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Ala Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Val Ser Gly Leu 
65                  70                  75                  80  


Leu Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Gly Tyr Gly Gly Gly 
                85                  90                  95      


Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210> 127
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPD1 VH-CDR1 peptide

<400> 127
Gly Val Ser Ile Thr Ser Asn Thr Tyr Trp 
1               5                   10  


<210> 128
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPD1 VH-CDR2 peptide

<400> 128
Leu Ser Tyr Ser Gly Asp Thr 
1               5           


<210> 129
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPD1 VH-CDR3 peptide

<400> 129
Ala Arg Asp Pro Asp Ile Ile Arg Asn Phe Gln Phe Asp Tyr 
1               5                   10                  


<210> 130
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPD1 VL-CDR1 peptide

<400> 130
Gln Ile Leu Tyr Met Ser His 
1               5           


<210> 131
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPD1 VL-CDR2 peptide

<400> 131
Gly Ala Ser 
1           


<210> 132
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPD1 VL-CDR2 peptide

<400> 132
Leu Ile Tyr Gly Ala Ser Ile Arg Ala 
1               5                   


<210> 133
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPD1 VL-CDR3 peptide

<400> 133
Gln Gln Tyr Gly Ala Ser Pro Thr 
1               5               


<210> 134
<211> 122
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPD1 VH polypeptide

<400> 134
Gln Val Gln Leu Gln Glu Ser Asp Pro Arg Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ser Val Ser Gly Val Ser Ile Thr Ser Asn 
            20                  25                  30          


Thr Tyr Trp Trp Ala Trp Ile Arg Gln Pro Pro Gly Lys Lys Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Leu Ser Tyr Ser Gly Asp Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Thr Ser Arg Val Thr Ile Ser Arg Asp Ile His Gln Asn Gln Phe 
65                  70                  75                  80  


Phe Leu Glu Leu Asn Ser Val Thr Ala Ala Asp Thr Ala Met Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Pro Asp Ile Ile Arg Asn Phe Gln Phe Asp Tyr Trp 
            100                 105                 110         


Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210> 135
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPD1 VL polypeptide

<400> 135
Glu Ile Val Leu Thr Gln Ser Pro Gly Ile Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Val Ser Gln Ile Leu Tyr Met Ser 
            20                  25                  30          


His Leu Ala Trp Tyr Gln His Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ile Arg Ala Thr Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ala Ser Pro 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Met Val Glu Ile Lys 
            100                 105         


<210> 136
<211> 358
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42 VH polynucleotide

<400> 136
gaggtgcagc tggtggagtc tgggggaggc ttggtaaagc cgggggggtc ccttagactc       60

tcctgtgcag cctctggttt cactttcaat gacgcctgga tgaactgggt ccgccaggct      120

ccaggaaagg ggctggagtg ggtcgcccgc attaaaaaga aacatgaagg tgttacgaca      180

gactaccctg catccgtgag aggcagattc accatctcaa gagatgattc taaaaacaca      240

gtgtatctgc agatgggcag actgagaatc gaggacactg ccatatatta ctgtaccaca      300

aggatagtga ctaccaatga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210> 137
<211> 357
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42-v2016 VH polynucleotide

<400> 137
gaggtgcagc tggtcgaatc tggcggggga ctggtgaaac ctggcggctc tctgaggctg       60

agttgcgccg cttcaggctt caccttcaac gacgcatgga tgaattgggt gcgacaggca      120

cctggaaagg gactggagtg ggtcggccgg atcaagaaaa agcacgaagg ggtgaccaca      180

gattaccctg ctagcgtccg gggaagattc actattagca gagacgattc caaaaacacc      240

gtgtatctgc agatgggcag gctgcgcatc gaggacaccg ccatctacta ttgtactacc      300

cgcatcgtga caactaatga ttactggggg cagggaaccc tggtgacagt cagctcc         357


<210> 138
<211> 357
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42-FR-GL-VH/KPN42-FR-GL-C105A-VL VH polynucleotide

<400> 138
gaggtgcagc tggtcgaatc tggcggggga ctggtgaagc ctggcggctc tctgcgactg       60

agttgcgccg cttcaggctt cacctttaac gacgcttgga tgaattgggt gaggcaggca      120

cctggaaaag gactggagtg ggtgggacgc atcaagaaaa agcacgaagg ggtgaccaca      180

gattacgcag cccctgtcaa aggccggttc acaattagca gagacgattc caagaacact      240

ctgtatctgc agatgaatag cctgaaaacc gaggacacag ccgtgtacta ttgtactacc      300

agaatcgtca caactaacga ttactggggg cagggaactc tggtgaccgt cagctcc         357


<210> 139
<211> 358
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS3 VH polynucleotide

<400> 139
cagggacagt tggtggactc tgggggaggc gtggtccagc ggggggggtc tcagagactc       60

tcctgcgcag cgtctggatt cagcttcaga gactatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggccttt atatcatatg atgggagaga tcaatactat      180

gcagactccg tgaagggccg attcatcatc tccagagaca attccaagaa cacgctgtct      240

ctgcaaatga acagcctgag acctgaggac acggctgtct attactgtgg gcctttttat      300

aaccccagtc tctactaccc cccctggggc cacggacttc cggtcatcgt ctcctcag        358


<210> 140
<211> 364
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN70 VH polynucleotide

<400> 140
caggtgcagc tgcaggagtc gggcccggga ctggtgaagc cttcggagac cctgtctctc       60

acctgcactg tctctggtgg ctccatcagt acttactact ggaactggat ccggcagtcc      120

ccagggaagg aattggagtg gattgcaaat atacatcaaa gtgggaccac ctactacaac      180

ccctccctca agagtcgagt caccatgtca gtagacacgt ccaagaacca gttctccctg      240

aaggtgatct ctgtgactgc tgcggacacg gccgtgtatt actgtgcgag agagtccgac      300

gatggctaca agtggaacta ctttgactac tggggccagg gaaccctagt caccgtctcc      360

tcag                                                                   364


<210> 141
<211> 358
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179 VH polynucleotide

<400> 141
gaggtgcagg tggtggagtc tgggggaggc ttggtaaagc cgggggggtc ccttagactc       60

tcctgtgcag cctctggttt cactttcaat aacgcctgga tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtcggccgt attaaaagga aagctgatgg tgagacaaca      180

gactaccctg catccgtgaa aggcagattc accgtctcaa gagatgattc aaaaaacacg      240

atatatctgc agatgaacag cctgaaaacc gaggacacag ccatatatta ctgtaccaca      300

aggatagtga ctaccaatga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210> 142
<211> 364
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN44 VH polynucleotide

<400> 142
caggtgcagc tgcaggagtc gggcccggga ctggtgaagc cttcggagac cctgtctctc       60

acctgcactg tgtccggtgg ctccaccagt agttactact ggaactggat ccggcaggcc      120

ccagggaagc cattgcagtg gattgcaaat atacatcacg gtgggaccac ttattacaac      180

ccctccctca ggagtcgggt caccatgtct ctggacactt ccaataacca gttctccctg      240

aagctgacct ctgtgactgc tgcggacacg gccgtctatt tctgtgcgag agagtccgac      300

gatggctaca ggtggaacta ctttgactac tggggccagg gagtcctggt caccgtctcc      360

tcag                                                                   364


<210> 143
<211> 373
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN17 VH polynucleotide

<400> 143
gaggtgcagc tggtggagtc cgggggaggc ttggttcagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt cacttctgga tgcactgggt ccgccaagct      120

ccagggcagg ggctggtgtg ggtcgcacgt attgatggtt ctgtgacaaa cttgaggtac      180

gcgggctccg tggaggggcg attcaccatc tccagagaca acgccaagaa cacgctgtat      240

ttgcaaatga acagtctgag agacgaggac acggctgtat attactgtgc aagagatttg      300

gtaggaattg gcacgccggc cgggtacggt atggacgtct ggggccaagg gaccacggtc      360

accgtctcct cag                                                         373


<210> 144
<211> 357
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      6F6 VH polynucleotide

<400> 144
caggttcacc tacaacagtc tggttctgaa ctgaggagtc ctgggtcttc agtaaagctt       60

tcatgcaagg attttgattc agacgtcttc cctattgctt atatgggttg gattaggcag      120

cagcctgggc atggatttga ctggattggg gacatactcc caaatattgg tagaacaatc      180

tatggagaga agtttgagga caaagccaca ctggatgcag acacagtgtc caacacagcc      240

tacttggagc tcagcagtct gacatctgag gactctgcta tctactattg tgcaaggagg      300

gggacgtcgg gggctatgga ctactggggt caaggaacct cagtcaccgt ctcctca         357


<210> 145
<211> 355
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL26 VH polynucleotide

<400> 145
gaggtgcagc tggtggagtc tgggggaggc ttggtccagt cgggggggtc cctgagactc       60

tcctgtgaaa cctctggatt catttttggt agttcttgga tgacctgggt ccgccaggct      120

ccagggaaag ggctggagtg ggtggccacc ataaaccctg atggaagtgc gacaagctat      180

gaggactctg tgaggggccg attcgccgtc tccagagaca acgccaagaa ctcagtgtat      240

ctgcaaatga acagcctgag agccgaggac acggccgtgt acttctgtac aaggaataag      300

gcatacaatg cccttgacta ctggggccag ggaaccctgg tcaccgtctc ctcag           355


<210> 146
<211> 361
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS18 VH polynucleotide

<400> 146
gaggttcgcc tggtggagtc tgggggaggc ttggtaaagc ctggggggtc cctaagactc       60

tcctgtgcag cctcaggatt cactttcaaa aacgcctgga tgagctggat ccgccaggct      120

ccagggaagg ggctggagtg ggttggccgt gttaaaaacg aagttgatgg ggggacaata      180

gactacggtg tgcccgtgag aggcagattc accatctcaa gagacgattc acaaggcacg      240

ctgtctctgg agatgaacag cctgagagag gatgacacag ggatttatta ctgtcgggct      300

ttttggagtg gttttcctgc cggatactgg ggccagggaa ccctggtcag cgtctcctca      360

g                                                                      361


<210> 147
<211> 361
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS24 VH polynucleotide

<400> 147
gagctgcacc tggtggagtc tgggggaggc ttggtaaagc ctggggggtc ccttagactc       60

tcctgtgcag cctcaggatt cactttcaaa aacgcctgga tgagctggat ccgccaggct      120

ccagggaagg ggctggagtg ggttggccgt gttaaaagcg aagttgatgg ggggacaaca      180

gactacggtg tgcccgtgag aggcagattc accatctcaa gagatgattc acaaagcacg      240

ctgtctctgg agatgagcag cctgcaagac gatgacacag gcgtttatta ctgtcgggct      300

ttttggagtg attttcaaac cggctactgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210> 148
<211> 361
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44 VH polynucleotide

<400> 148
gaggtgcacc tggtggagtc tgggggaggc ttggtaaagc ctggggggtc ccttagactc       60

tcctgtgcag cctcaggatt cactttcaaa aacgcctgga tgagctggat ccgccaggct      120

ccagggaagg ggctggagtg ggttggccgt gttaaaagcg aagttgatgg ggggacaata      180

gactacggtg tgcccgtgag aggcagattc accatctcaa gagatgattc acaaggcaca      240

ctgtctctgg agatgaacag cctgaaagac gatgacacag gcgtttatta ttgtcgggct      300

ttttggagtg gttttcctac cggatactgg ggccagggag ccctggtcag cgtctcctca      360

g                                                                      361


<210> 149
<211> 355
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS30 VH polynucleotide

<400> 149
gagatgcagt tggtagagtc tgggggaggc ttggtccagc ctggggtgtc cctgagactc       60

tcctgtgtag actctggatt cagttttagt acctcttggt tggcctgggt ccgccaggct      120

ccagggaagg ggctggagtg gctggccaac atagatccag atggaagcac gagaaatcat      180

gtggactctg tgaggggccg attcaccatc tccagagaca acgccaagaa ttcactgtat      240

ctccagatga acagcctgag agccgaggac acggccgtct attactgtgc gagagactat      300

gcctacaatc gctttgacta ctggggccag ggaaccatgg tcaccgtctc ctcag           355


<210> 150
<211> 367
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPD1 VH polynucleotide

<400> 150
caggtgcagc tgcaggagtc ggacccacga ctggtgaagc cttcggagac cctgtccctc       60

acctgtagtg tctctggtgt ctccatcacc agtaacactt actggtgggc ctggatccgc      120

cagcccccag ggaagaaact ggagtggatt gggagtctct cttacagtgg ggacacctac      180

tacaacccgt ccctcacgag tcgcgtcacc atatcaagag atatccatca gaaccaattt      240

ttcctggagt tgaactctgt gaccgccgcc gacacggcca tgtattactg tgcgagagat      300

cccgacatca ttcgcaattt ccagtttgac tactggggcc ggggaaccct ggtcaccgtc      360

tcctcgg                                                                367


<210> 151
<211> 330
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42 VL polynucleotide

<400> 151
cagtctgccc tgactcagcc tccctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgatgttggt gcttacgact atgtctcctg gtaccaacag      120

tacgcaggca aagtccccaa acacataatt tatgatgtca atgagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggccg ccctgaccat ctctgggctc      240

caggctgagg atgaggctga ttattattgc tgctcatatg caggcggtga catctttgtc      300

ttcggaactg ggactcaggt caccgtccta                                       330


<210> 152
<211> 330
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42-v2016 VL polynucleotide

<400> 152
cagtctgccc tgacccagcc taggtctgtg agtgggtcac ccggacagag tgtcacaatc       60

tcatgcaccg gaacaagctc cgacgtgggc gcttacgatt atgtctcttg gtaccagcag      120

caccccggga aggcacctaa actgatgatc tacgacgtga acaagcggcc aagtggcgtc      180

cccgatagat tcagcggctc caaatctggg aatacagcta gcctgactat ctccggcctg      240

caggcagagg acgaagccga ttactattgt gccagctacg ctggcgggga cattttcgtg      300

tttggaactg gcaccaaggt gaccgtcctg                                       330


<210> 153
<211> 330
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN42-FR-GL-VH/KPN42-FR-GL-C105A-VL VL polynucleotide

<400> 153
cagtctgccc tgacccagcc taggtctgtg agtgggtcac ccggacagag tgtcacaatc       60

tcatgcaccg gaacaagctc cgacgtgggc gcttacgatt atgtctcttg gtaccagcag      120

caccccggga aggcacctaa actgatgatc tacgacgtga acaagcggcc aagtggcgtc      180

cccgatagat tcagcggctc caaatctggg aatacagcta gcctgactat ctccggcctg      240

caggcagagg acgaagccga ttactattgt gccagctacg ctggcgggga cattttcgtg      300

tttggaactg gcaccaaggt gaccgtcctg                                       330


<210> 154
<211> 325
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS3 VL polynucleotide

<400> 154
gaggttgtct tgacacagtc tccagccact ctgtctttgt ctccagggga aagagccacc       60

ctctcctgta gggccagtca gagcattagc agccaattag cgtggtacca acagaaacct      120

ggccaggctc ccaggctcct catccatgat gcatccaaca gggacactgg cgtcccagac      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagattttg ctatgtatta ctgtctccag cgtaacaact ggcctccgtg gacgttcggc      300

caagggacca aggtggaaat caaac                                            325


<210> 155
<211> 325
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN70 VL polynucleotide

<400> 155
gaaattgtgt tgacacagtc tccagcctcc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gattgttacc aactacttag cctggtatca acataaacct      120

ggccaggctc ccaggctcct catctttgat atgtccatta gggccgctgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag ccttgagcct      240

gaagattttg cagtttatta ctgtcaacac cgtagcaact ggcctctatt cactttcggc      300

cctgggacca aagtggatat caaac                                            325


<210> 156
<211> 334
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179 VL polynucleotide

<400> 156
cagtctgccc tgactcagcc tccctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgatgttggt tattacgact atgtctcctg gtaccaacag      120

caccacccag gcaaagcccc caaacacatg atttatgatg tcaataagcg gccctcaggg      180

gtccctgatc gcttctctgg ctccaagtct ggcaacacgg cctccctgac catctctggg      240

ctccaggctg aggatgaggc tgattattat tgctgttcat atgcaggcgg tgacactttt      300

gtcttcggaa ctgggaccaa ggtcaccgtc ctag                                  334


<210> 157
<211> 325
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN44 VL polynucleotide

<400> 157
gaaattgtgt tgacacagtc tccagcctcc ctgtctttgt ctccagggga cagagccacc       60

ctctcctgca gggccagtca gacgattacc aactacttag cctggtacca acataaacct      120

ggccaggctc ccagactcct catctttgat atgtcgaaaa gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag ccttgagcct      240

gaagattttg cagtttacta ctgtcaacac cgtagcaact ggcctctatt cactttcggc      300

cctgggacca acgtggatat caaac                                            325


<210> 158
<211> 322
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN17 VL polynucleotide

<400> 158
gacatccagt tgacccagtc tccatccttc ctgtctgcct ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gggcattagc acttatttag cctggtatca acaaaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccactt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca caatcaacag cctgcagtct      240

gaagattttg caacttacta ctgtcagcag cttactagtc acctctacac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210> 159
<211> 336
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      6F6 VL polynucleotide

<400> 159
gatgttgtga tgacccaaac tccactcttc ctgcctgtca gtcttggaga tcaagcctcc       60

atctcttgca gatctagtca gggccttgta cacagtactg gaaacacctt tttacattgg      120

tacctgcaga agccaggcca gtctccaaag ctcctgatct acaaagtttc caaccgattt      180

tctggggtcc cagacaggtt cagtggcagt ggatcaggga cagatttcac actcaagatc      240

agcagagtgg aggctgagga tctgggaatt tatttctgct ctcaaagtac acatattccg      300

tacacgttcg gaggggggac caagctggaa ataaaa                                336


<210> 160
<211> 325
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL26 VL polynucleotide

<400> 160
cagtctgccc tgactcagcc tccctccgcg tccgggtctc ctggacaatc agtcaccctc       60

tcctgcactg gaaccagcag tgacgttggt ggtaataact atgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatcatt tatgaggtca gtaagcggcc ctcaggggtc      180

cctaatcgtt tctctggctc caagtctggc aacacggcct ccctgaccgt ctctgggctc      240

caggctgagg atgaggctga ttattactgc agctcatttg gaggtagtaa gatgttcggc      300

ggagggacca agctgaccgt cctag                                            325


<210> 161
<211> 331
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS18 VL polynucleotide

<400> 161
cagtctgtgt tgacgcagcc gccctcactg tctgcggccc caggacagac ggtcaccatc       60

gcctgctctg gaagtagatc caacattggg agtgattccg tctcctggtt ccagcagttc      120

ccaggaacag cccccagagt cctcatgtat gacaataata agcgaccctc aggcatttct      180

gaccgattct ctggctccaa gtctggcacg tcagtcaccc tggacatcac cggactccag      240

actggggacg aggccgatta ttactgcgca acatgggata gcagcctgag tgcttatgtc      300

ttcggatctg ggaccaaggt caccgtccta a                                     331


<210> 162
<211> 331
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS24 VL polynucleotide

<400> 162
cagtctgtgt tgacgcagcc gccctcagtg tctgcggccc caggacagac ggtcaccatc       60

gcctgctctg gaagtagctc caacattggg agtgattccg tatcctggtt ccagcagctc      120

ccaggaacag cccccagagt cctcatgtat gaaaataata agcgaccctc agggatttct      180

gaccgattct ctggctccaa gtctggcacg tcagtcaccc tgggcatcac cggactccag      240

actggggacg aggccgatta ttactgcgca gcatgggata gcagcctacg tgcttatgtc      300

ttcggatctg ggaccaaggt caccgtccta g                                     331


<210> 163
<211> 331
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44 VL polynucleotide

<400> 163
cagtctgtgt tgacgcagcc gccctcactg tctgcggccc ctggacagac gatcaccatc       60

gcctgctctg gaactagttc caacattggg agtgattccg tatcctggtt ccagcaattc      120

ccaggaacag cccccagagt cctcatatat gagaataata agcgaccctc aggcatttct      180

gaccgattct ctggctccaa gtctggcacg tcagtcacac tgggcatcac cggactccag      240

actggggacg aggccgatta ttactgcgca acatgggata gcagcctgag tgcttatgtc      300

ttcggatctg ggaccaaggt caccgtccta g                                     331


<210> 164
<211> 325
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS30 VL polynucleotide

<400> 164
cagtctgccc tgactcagcc tccctccgcg tccgggtctc ctggacagtc agtcgtcatc       60

tcctgcactg gaaccagcag tgacattggg gctaataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcttgctt tatgaggtca ataagcggcc ctcaggggtc      180

cctgatcgct tctctgcctc caagtctggc aacacggcct ccctgaccgt ctctgggctc      240

ctggctgagg atgaggctga ttattactgc tgcggatatg gaggcgggag ggtgttcggc      300

ggagggacca agctgaccgt cctac                                            325


<210> 165
<211> 322
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPD1 VL polynucleotide

<400> 165
gaaattgtgt tgacgcagtc tccaggcatc ctgtctttgt ctccagggga gagagccacc       60

ctctcttgca gggtcagtca gattctttac atgtctcatt tggcctggta tcagcataaa      120

cctggacagg ctcccagact cctcatctat ggtgcgtcca tcagggccac tggcgtccca      180

gacaggttca gtggcagtgg gtccgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggcg cctcaccgac gttcggccaa      300

gggacaatgg tggaaatcaa ac                                               322


<210> 166
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-1-2-4-GL N35S-VH/KPN179-FR-GL-C105A-VL VH-CDR1 peptide

<400> 166
Gly Phe Thr Phe Ser Asn Ala Trp 
1               5               


<210> 167
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-1-2-4-GL N35S-VH/KPN179-FR-GL-C105A-VL VH-CDR2 peptide

<400> 167
Ile Lys Arg Lys Ala Asp Gly Glu Thr Thr 
1               5                   10  


<210> 168
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-1-2-4-GL N35S-VH/KPN179-FR-GL-C105A-VL VH-CDR3 peptide

<400> 168
Thr Thr Arg Ile Val Thr Thr Asn Asp Tyr 
1               5                   10  


<210> 169
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-GL N35S-VH/KPN179-FR-GL-C105A-VL VH-CDR1 peptide

<400> 169
Gly Phe Thr Phe Ser Asn Ala Trp 
1               5               


<210> 170
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-GL N35S-VH/KPN179-FR-GL-C105A-VL VH-CDR2 peptide

<400> 170
Ile Lys Arg Lys Ala Asp Gly Glu Thr Thr 
1               5                   10  


<210> 171
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-GL N35S-VH/KPN179-FR-GL-C105A-VL VH-CDR3 peptide

<400> 171
Thr Thr Arg Ile Val Thr Thr Asn Asp Tyr 
1               5                   10  


<210> 172
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL36 VH-CDR1 peptide

<400> 172
Gly Phe Thr Phe Ile Ser Ser Trp 
1               5               


<210> 173
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL36 VH-CDR2 peptide

<400> 173
Ile Asn Pro Asp Gly Thr Glu Thr 
1               5               


<210> 174
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL36 VH-CDR3 peptide

<400> 174
Ala Arg Asn Lys Ala Tyr Asn Ala His Asp Phe 
1               5                   10      


<210> 175
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-1-2-4-GL N35S-VH/KPN179-FR-GL-C105A-VL VL-CDR1 peptide

<400> 175
Ser Ser Asp Val Gly Tyr Tyr Asp Tyr 
1               5                   


<210> 176
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-1-2-4-GL N35S-VH/KPN179-FR-GL-C105A-VL VL-CDR2 peptide

<400> 176
Asp Val Asn 
1           


<210> 177
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-1-2-4-GL N35S-VH/KPN179-FR-GL-C105A-VL VL-CDR2 peptide

<400> 177
Met Ile Tyr Asp Val Asn Lys Arg Pro 
1               5                   


<210> 178
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-1-2-4-GL N35S-VH/KPN179-FR-GL-C105A-VL VL-CDR3 peptide

<400> 178
Ala Ser Tyr Ala Gly Gly Asp Thr Phe Val 
1               5                   10  


<210> 179
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-GL N35S-VH/KPN179-FR-GL-C105A-VL VL-CDR1 peptide

<400> 179
Ser Ser Asp Val Gly Tyr Tyr Asp Tyr 
1               5                   


<210> 180
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-GL N35S-VH/KPN179-FR-GL-C105A-VL VL-CDR2 peptide

<400> 180
Asp Val Asn 
1           


<210> 181
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-GL N35S-VH/KPN179-FR-GL-C105A-VL VL-CDR2 peptide

<400> 181
Met Ile Tyr Asp Val Asn Lys Arg Pro 
1               5                   


<210> 182
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-GL N35S-VH/KPN179-FR-GL-C105A-VL VL-CDR3 peptide

<400> 182
Ala Ser Tyr Ala Gly Gly Asp Thr Phe Val 
1               5                   10  


<210> 183
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL36 VL-CDR1 peptide

<400> 183
Ser Ser Asp Val Gly Gly Asn Asn Phe 
1               5                   


<210> 184
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL36 VL-CDR2 peptide

<400> 184
Glu Val Asn 
1           


<210> 185
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL36 VL-CDR2 peptide

<400> 185
Ile Ile Tyr Glu Val Asn Lys Arg Pro 
1               5                   


<210> 186
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL36 VL-CDR3 peptide

<400> 186
Gly Ala Phe Gly Gly Ser Lys Met 
1               5               


<210> 187
<211> 119
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-1-2-4-GL N35S-VH/KPN179-FR-GL-C105A-VL VH 
      polypeptide

<400> 187
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Ala 
            20                  25                  30          


Trp Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Ile Lys Arg Lys Ala Asp Gly Glu Thr Thr Asp Tyr Pro Ala 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Val Ser Arg Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Ile Tyr Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Ala Ile Tyr 
                85                  90                  95      


Tyr Cys Thr Thr Arg Ile Val Thr Thr Asn Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210> 188
<211> 119
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-GL N35S-VH/KPN179-FR-GL-C105A-VL VH
      polypeptide

<400> 188
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Ala 
            20                  25                  30          


Trp Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Ile Lys Arg Lys Ala Asp Gly Glu Thr Thr Asp Tyr Ala Ala 
    50                  55                  60                  


Pro Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Thr Thr Arg Ile Val Thr Thr Asn Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210> 189
<211> 118
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL36 VH polypeptide

<400> 189
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Ser Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Glu Thr Ser Gly Phe Thr Phe Ile Ser Ser 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Thr Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Thr Ile Asn Pro Asp Gly Thr Glu Thr Pro Tyr Ala Asp Ser Leu 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Thr Lys Lys Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Ile His Ser Leu Arg Ala Asp Asp Thr Ala Val Tyr Phe Cys 
                85                  90                  95      


Ala Arg Asn Lys Ala Tyr Asn Ala His Asp Phe Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Met Val Ser Ser 
        115             


<210> 190
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-1-2-4-GL N35S-VH/KPN179-FR-GL-C105A-VL VL
      polypeptide

<400> 190
Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Tyr Tyr 
            20                  25                  30          


Asp Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Asn Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ser Tyr Ala Gly Gly 
                85                  90                  95      


Asp Thr Phe Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210> 191
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-GL N35S-VH/KPN179-FR-GL-C105A-VL VL polypeptide

<400> 191
Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Tyr Tyr 
            20                  25                  30          


Asp Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Asn Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ser Tyr Ala Gly Gly 
                85                  90                  95      


Asp Thr Phe Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210> 192
<211> 108
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL36 VL polypeptide

<400> 192
Gln Ser Ala Leu Thr Gln Pro Pro Ser Ala Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Asn 
            20                  25                  30          


Asn Phe Val Ser Trp Tyr Gln Gln Tyr Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Ile Ile Tyr Glu Val Asn Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Val Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gly Ala Phe Gly Gly Ser 
                85                  90                  95      


Lys Met Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210> 193
<211> 357
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-1-2-4-GL N35S-VH/KPN179-FR-GL-C105A-VL VH polynucleotide

<400> 193
gaggtgcagc tggtcgaatc cggcggggga ctggtgaaac ctggcggctc tctgcgactg       60

agttgcgccg cttcaggctt cacctttagc aacgcatgga tgaattgggt gagacaggca      120

cctggaaagg gactggagtg ggtcggccgg atcaagagaa aagctgacgg ggaaaccaca      180

gattaccctg catctgtgaa gggcaggttc acagtcagcc gcgacgattc caaaaacact      240

atctacctgc agatgaatag tctgaagacc gaggacacag ccatctacta ttgtactacc      300

cggattgtga caactaacga ttactggggg cagggaactc tggtgaccgt cagctcc         357


<210> 194
<211> 357
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-GL N35S-VH/KPN179-FR-GL-C105A-VL VH polynucleotide

<400> 194
gaggtgcagc tggtcgaatc tggcggggga ctggtgaaac ctggcggctc tctgcgactg       60

agttgcgccg cttcaggctt cacctttagc aacgcttgga tgaattgggt gagacaggca      120

cctggaaagg gactggagtg ggtgggacgg atcaagagaa aagccgacgg ggaaaccaca      180

gattacgcag cccctgtgaa gggcaggttc acaattagcc gcgacgattc caaaaacact      240

ctgtatctgc agatgaatag cctgaagacc gaggacacag ccgtgtacta ttgtactacc      300

cggatcgtca caactaacga ttactggggg cagggaactc tggtgaccgt cagctcc         357


<210> 195
<211> 355
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL36 VH polynucleotide

<400> 195
gaggtgcagc tggtggagtc tgggggaggc gtggtccagt ctggggggtc cctgagactc       60

tcctgtgaga cttctggatt cacctttata agttcttgga tgagttgggt ccgccaggct      120

ccagggacag gactggagtg ggtggccacc attaaccctg atggaactga gacaccctac      180

gcggactcgc tgaagggccg cttcaccatc tccagagaca acaccaagaa gtcactttat      240

ctgcaaatcc atagcctgag agccgacgac acggccgtct atttctgtgc aaggaataag      300

gcatacaatg cccatgactt ctggggccag ggaaccctgg tcaccgtctc ctcag           355


<210> 196
<211> 330
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-1-2-4-GL N35S-VH/KPN179-FR-GL-C105A-VL VL polynucleotide

<400> 196
cagtctgccc tgactcagcc taggtctgtg agtgggtcac ccggacagag tgtcacaatc       60

tcatgcaccg gaacaagctc cgacgtgggc tactatgatt acgtctcttg gtatcagcag      120

caccccggga aggctcctaa actgatgatc tacgacgtga acaagcggcc aagtggcgtc      180

cccgatagat tcagcggctc caaatctggg aatacagcaa gcctgactat ttccggcctg      240

caggcagagg acgaagccga ttactattgt gccagctatg ctggcgggga caccttcgtg      300

tttggaactg gcaccaaggt gacagtcctg                                       330


<210> 197
<211> 330
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPN179-FR-GL N35S-VH/KPN179-FR-GL-C105A-VL VL polynucleotide

<400> 197
cagtctgccc tgactcagcc taggtctgtg agtgggtcac ccggacagag tgtcacaatc       60

tcatgcaccg gaacaagctc cgacgtgggc tactatgatt acgtctcttg gtatcagcag      120

caccccggga aggctcctaa actgatgatc tacgacgtga acaagcggcc aagtggcgtc      180

cccgatagat tcagcggctc caaatctggg aatacagcaa gcctgactat ttccggcctg      240

caggcagagg acgaagccga ttactattgt gccagctatg ctggcgggga caccttcgtg      300

tttggaactg gcaccaaggt gacagtcctg                                       330


<210> 198
<211> 325
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPL36 VL polynucleotide

<400> 198
cagtctgccc tgactcagcc tccctccgcg tccgggtctc ctggacaatc agtcaccatc       60

tcctgcactg gaaccagtag tgacgtaggt ggtaataact ttgtctcctg gtaccaacag      120

tatccaggca aagcccccaa actcattatt tatgaggtca ataagcggcc ctcaggggtc      180

cctgatcgtt tctctggctc caagtctggc aacacggcct ccctgaccgt ctctgggctc      240

caggctgagg atgaggctga ttattactgc ggcgcatttg gaggtagcaa gatgttcggc      300

ggagggacca agctgaccgt cctag                                            325


<210> 199
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-v2017/KPS-44-G2/KPS-44-G3 VH-CDR3 peptide

<400> 199
Arg Ala Phe Phe Ser Gly Phe Pro Thr Gly Tyr 
1               5                   10      


<210> 200
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-v2017/KPS-44-G1/KPS-44-G3 VL-CDR1 peptide

<400> 200
Ser Ser Asn Ile Gly Ser Asn Tyr 
1               5               


<210> 201
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-v2017/KPS-44-G1/KPS-44-G2 VL-CDR3 peptide

<400> 201
Ala Thr Phe Asp Ser Ser Leu Ser Ala Tyr Val 
1               5                   10      


<210> 202
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-v2017/KPS44-G2/KPS44-G3 VH polypeptide

<400> 202
Glu Val His Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Lys Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Val Lys Ser Glu Val Asp Gly Gly Thr Ile Asp Tyr Gly Val 
    50                  55                  60                  


Pro Val Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Gln Gly Thr 
65                  70                  75                  80  


Leu Ser Leu Glu Met Asn Ser Leu Lys Asp Asp Asp Thr Gly Val Tyr 
                85                  90                  95      


Tyr Cys Arg Ala Phe Phe Ser Gly Phe Pro Thr Gly Tyr Trp Gly Gln 
            100                 105                 110         


Gly Ala Leu Val Ser Val Ser Ser 
        115                 120 


<210> 203
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-v2017/KPS44-G1 VL polypeptide

<400> 203
Gln Ser Val Leu Thr Gln Pro Pro Ser Leu Ser Ala Ala Pro Gly Gln 
1               5                   10                  15      


Thr Ile Thr Ile Ala Cys Ser Gly Thr Ser Ser Asn Ile Gly Ser Asn 
            20                  25                  30          


Tyr Val Ser Trp Phe Gln Gln Phe Pro Gly Thr Ala Pro Arg Val Leu 
        35                  40                  45              


Ile Tyr Glu Asn Asn Lys Arg Pro Ser Gly Ile Ser Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Val Thr Leu Gly Ile Thr Gly Leu Gln 
65                  70                  75                  80  


Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Phe Asp Ser Ser Leu 
                85                  90                  95      


Ser Ala Tyr Val Phe Gly Ser Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210> 204
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G2 VL polypeptide

<400> 204
Gln Ser Val Leu Thr Gln Pro Pro Ser Leu Ser Ala Ala Pro Gly Gln 
1               5                   10                  15      


Thr Ile Thr Ile Ala Cys Ser Gly Thr Ser Ser Asn Ile Gly Ser Asp 
            20                  25                  30          


Ser Val Ser Trp Phe Gln Gln Phe Pro Gly Thr Ala Pro Arg Val Leu 
        35                  40                  45              


Ile Tyr Glu Asn Asn Lys Arg Pro Ser Gly Ile Ser Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Val Thr Leu Gly Ile Thr Gly Leu Gln 
65                  70                  75                  80  


Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Phe Asp Ser Ser Leu 
                85                  90                  95      


Ser Ala Tyr Val Phe Gly Ser Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210> 205
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G3 VL polypeptide

<400> 205
Gln Ser Val Leu Thr Gln Pro Pro Ser Leu Ser Ala Ala Pro Gly Gln 
1               5                   10                  15      


Thr Ile Thr Ile Ala Cys Ser Gly Thr Ser Ser Asn Ile Gly Ser Asn 
            20                  25                  30          


Tyr Val Ser Trp Phe Gln Gln Phe Pro Gly Thr Ala Pro Arg Val Leu 
        35                  40                  45              


Ile Tyr Glu Asn Asn Lys Arg Pro Ser Gly Ile Ser Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Val Thr Leu Gly Ile Thr Gly Leu Gln 
65                  70                  75                  80  


Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Trp Asp Ser Ser Leu 
                85                  90                  95      


Ser Ala Tyr Val Phe Gly Ser Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210> 206
<211> 360
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-v2017 VH polynucleotide

<400> 206
gaggtgcacc tggtcgaatc cggcggggga ctggtgaaac caggcgggtc tctgagactg       60

agttgcgccg cttcaggctt caccttcaag aacgcatgga tgagctggat tagacaggca      120

cctgggaagg gactggagtg ggtgggccgc gtcaaatctg aagtggatgg aggcaccatc      180

gactacgggg tgcctgtccg gggaagattc accattagcc gagacgattc ccagggcaca      240

ctgtctctgg agatgaatag tctgaaggac gatgacactg gggtgtacta ttgtagagct      300

ttcttttcag gatttcctac cggctattgg ggacaggggg ccctggtgag cgtcagctcc      360


<210> 207
<211> 360
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G1 VH polynucleotide

<400> 207
gaggtacacc ttgtagaaag tgggggtggg cttgtcaagc ctgggggaag tttgagactg       60

agttgcgccg caagtggctt cacgtttaag aacgcatgga tgtcctggat tagacaagcc      120

cccggtaaag gtttggaatg ggtaggacga gttaagtctg aggttgacgg ggggacgata      180

gattacggtg ttcccgtgcg cggcagattc acgataagtc gagacgactc tcagggtaca      240

cttagcctcg aaatgaatag cctcaaagac gatgatacag gcgtttatta ttgccgcgca      300

ttctggagtg gcttcccgac tgggtactgg gggcaaggtg ctcttgtctc agtgtcatcc      360


<210> 208
<211> 360
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G2/KPS44-G3 VH polynucleotide

<400> 208
gaggtacacc ttgtagaaag tgggggtggg cttgtcaagc ctgggggaag tttgagactg       60

agttgcgccg caagtggctt cacgtttaag aacgcatgga tgtcctggat tagacaagcc      120

cccggtaaag gtttggaatg ggtaggacga gttaagtctg aggttgacgg ggggacgata      180

gattacggtg ttcccgtgcg cggcagattc acgataagtc gagacgactc tcagggtaca      240

cttagcctcg aaatgaatag cctcaaagac gatgatacag gcgtttatta ttgccgcgca      300

ttctttagtg gcttcccgac tgggtactgg gggcaaggtg ctcttgtctc agtgtcatcc      360


<210> 209
<211> 330
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-v2017 VL polynucleotide

<400> 209
cagagcgtgc tgacacagcc cccttcactg agcgccgctc ctggacagac catcacaatt       60

gcttgctccg gcactagctc caacatcggg tccaattacg tgtcttggtt ccagcagttt      120

ccaggaaccg cacccagggt cctgatctat gagaacaata agcggccctc aggcattagc      180

gacagattct ccgggtctaa aagtggaact agcgtgaccc tgggaattac cggcctgcag      240

acaggcgacg aagcagatta ctattgtgcc accttcgatt ctagtctgag tgcctacgtc      300

tttggctctg ggacaaaagt gactgtcctg                                       330


<210> 210
<211> 330
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G1 VL polynucleotide

<400> 210
cagtccgttt tgacgcaacc cccgtcactg agtgctgcgc ctgggcagac cataacgatc       60

gcctgctcag ggaccagcag taatataggc tctaattatg tatcatggtt ccagcaattc      120

cctggcacgg cacctcgcgt actgatctac gaaaataata agcggccctc aggcatttca      180

gataggttct ctgggagcaa gagtggtaca agcgtaacgc tcggtatcac cggtctccag      240

acaggtgatg aagctgatta ctactgcgct acttttgata gctctctttc agcttacgtg      300

tttggttccg ggaccaaagt gacagtcctc                                       330


<210> 211
<211> 330
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G2 VL polynucleotide

<400> 211
cagtccgttt tgacgcaacc cccgtcactg agtgctgcgc ctgggcagac cataacgatc       60

gcctgctcag ggaccagcag taatataggc tctgattctg tatcatggtt ccagcaattc      120

cctggcacgg cacctcgcgt actgatctac gaaaataata agcggccctc aggcatttca      180

gataggttct ctgggagcaa gagtggtaca agcgtaacgc tcggtatcac cggtctccag      240

acaggtgatg aagctgatta ctactgcgct acttttgata gctctctttc agcttacgtg      300

tttggttccg ggaccaaagt gacagtcctc                                       330


<210> 212
<211> 330
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G3 VL polynucleotide

<400> 212
cagtccgttt tgacgcaacc cccgtcactg agtgctgcgc ctgggcagac cataacgatc       60

gcctgctcag ggaccagcag taatataggc tctaattatg tatcatggtt ccagcaattc      120

cctggcacgg cacctcgcgt actgatctac gaaaataata agcggccctc aggcatttca      180

gataggttct ctgggagcaa gagtggtaca agcgtaacgc tcggtatcac cggtctccag      240

acaggtgatg aagctgatta ctactgcgct acttgggata gctctctttc agcttacgtg      300

tttggttccg ggaccaaagt gacagtcctc                                       330


<210> 213
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G4 VH polypeptide

<400> 213
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Lys Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Val Lys Ser Glu Val Asp Ala Gly Thr Ile Asp Tyr Gly Val 
    50                  55                  60                  


Pro Val Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Arg Ala Phe Tyr Ser Gly Phe Pro Thr Gly Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210> 214
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G4 VH-CDR1 peptide

<400> 214
Gly Phe Thr Phe Lys Asn Ala Trp 
1               5               


<210> 215
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G4 VH-CDR2 peptide

<400> 215
Val Lys Ser Glu Val Asp Ala Gly Thr Ile 
1               5                   10  


<210> 216
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G4 VH-CDR3 peptide

<400> 216
Arg Ala Phe Tyr Ser Gly Phe Pro Thr Gly Tyr 
1               5                   10      


<210> 217
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G4 VL polypeptide

<400> 217
Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Ala Ala Pro Gly Gln 
1               5                   10                  15      


Lys Val Thr Ile Ala Cys Ser Gly Thr Ser Ser Asn Ile Gly Ser Asp 
            20                  25                  30          


Ala Val Ser Trp Phe Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Glu Asn Asn Lys Arg Pro Ser Gly Ile Ser Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Val Thr Leu Gly Ile Thr Gly Leu Gln 
65                  70                  75                  80  


Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Phe Glu Ser Ser Leu 
                85                  90                  95      


Ser Ala Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210> 218
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G4 VL-CDR1 peptide

<400> 218
Ser Ser Asn Ile Gly Ser Asp Ala 
1               5               


<210> 219
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G4 VL-CDR2 peptide

<400> 219
Glu Asn Asn 
1           


<210> 220
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G4 VL-CDR3 peptide

<400> 220
Ala Thr Phe Glu Ser Ser Leu Ser Ala Tyr Val 
1               5                   10      


<210> 221
<211> 360
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G4 VH polynucleotide

<400> 221
caggtacagc ttgtagaaag tgggggtggg cttgtcaagc ctgggggaag tttgagactg       60

agttgcgccg caagtggctt cacgtttaag aacgcatgga tgtcctggat tagacaagcc      120

cccggtaaag gtttggaatg ggtaggacga gttaagtctg aggttgacgc cgggacgata      180

gattacggtg ttcccgtgcg cggcagattc acgataagtc gagacgactc taagaataca      240

ctttacctcc agatgaatag cctcaaaacc gaggatacag ccgtttatta ttgccgcgca      300

ttctatagtg gcttcccgac tgggtactgg gggcaaggta ctcttgtcac agtgtcatcc      360


<210> 222
<211> 330
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G4 VL polynucleotide

<400> 222
cagtccgttt tgacgcaacc cccgtcagtg agtgctgcgc ctgggcagaa ggtgacgatc       60

gcctgctcag ggaccagcag taatataggc tctgatgctg tatcatggtt ccagcaactg      120

cctggcacgg cacctaaact gctgatctac gaaaataata agcggccctc aggcatttca      180

gataggttct ctgggagcaa gagtggtaca agcgtaacgc tcggtatcac cggtctccag      240

acaggtgatg aagctgatta ctactgcgct acttttgaga gctctctttc agcttacgtg      300

tttggtaccg ggaccaaagt gacagtcctc                                       330


<210> 223
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G6 VH polypeptide

<400> 223
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Lys Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Val Lys Ser Glu Val Asp Ala Gly Thr Ile Asp Tyr Gly Val 
    50                  55                  60                  


Pro Val Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Arg Ala Phe Tyr Ser Gly Phe Pro Thr Gly Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210> 224
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G6 VH-CDR1 peptide

<400> 224
Gly Phe Thr Phe Lys Asn Ala Trp 
1               5               


<210> 225
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G6 VH-CDR2 peptide

<400> 225
Val Lys Ser Glu Val Asp Ala Gly Thr Ile 
1               5                   10  


<210> 226
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G6 VH-CDR3 peptide

<400> 226
Arg Ala Phe Tyr Ser Gly Phe Pro Thr Gly Tyr 
1               5                   10      


<210> 227
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G6 VL polypeptide

<400> 227
Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Ala Ala Pro Gly Gln 
1               5                   10                  15      


Lys Val Thr Ile Ala Cys Ser Gly Thr Ser Ser Asn Ile Gly Ser Glu 
            20                  25                  30          


Ser Val Ser Trp Phe Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Glu Asn Asn Lys Arg Pro Ser Gly Ile Ser Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Val Thr Leu Gly Ile Thr Gly Leu Gln 
65                  70                  75                  80  


Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Phe Glu Ser Ser Leu 
                85                  90                  95      


Ser Ala Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210> 228
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G6 VL-CDR1 peptide

<400> 228
Ser Ser Asn Ile Gly Ser Glu Ser 
1               5               


<210> 229
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G6 VL-CDR2 peptide

<400> 229
Glu Asn Asn 
1           


<210> 230
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G6 VL-CDR3 peptide

<400> 230
Ala Thr Phe Glu Ser Ser Leu Ser Ala Tyr Val 
1               5                   10      


<210> 231
<211> 360
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G6 VH polynucleotide

<400> 231
caggtacagc ttgtagaaag tgggggtggg cttgtcaagc ctgggggaag tttgagactg       60

agttgcgccg caagtggctt cacgtttaag aacgcatgga tgtcctggat tagacaagcc      120

cccggtaaag gtttggaatg ggtaggacga gttaagtctg aggttgacgc cgggacgata      180

gattacggtg ttcccgtgcg cggcagattc acgataagtc gagacgactc taagaataca      240

ctttacctcc agatgaatag cctcaaaacc gaggatacag ccgtttatta ttgccgcgca      300

ttctatagtg gcttcccgac tgggtactgg gggcaaggta ctcttgtcac agtgtcatcc      360


<210> 232
<211> 330
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G6 VL polynucleotide

<400> 232
cagtccgttt tgacgcaacc cccgtcagtg agtgctgcgc ctgggcagaa ggtgacgatc       60

gcctgctcag ggaccagcag taatataggc tctgagtctg tatcatggtt ccagcaactg      120

cctggcacgg cacctaaact gctgatctac gaaaataata agcggccctc aggcatttca      180

gataggttct ctgggagcaa gagtggtaca agcgtaacgc tcggtatcac cggtctccag      240

acaggtgatg aagctgatta ctactgcgct acttttgaga gctctctttc agcttacgtg      300

tttggtaccg ggaccaaagt gacagtcctc                                       330


<210> 233
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G8 VH polypeptide

<400> 233
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Lys Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Val Lys Ser Glu Val Asp Ala Gly Thr Ile Asp Tyr Gly Val 
    50                  55                  60                  


Pro Val Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Arg Ala Phe Tyr Ser Gly Phe Pro Thr Gly Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210> 234
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G8 VH-CDR1 peptide

<400> 234
Gly Phe Thr Phe Lys Asn Ala Trp 
1               5               


<210> 235
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G8 VH-CDR2 peptide

<400> 235
Val Lys Ser Glu Val Asp Ala Gly Thr Ile 
1               5                   10  


<210> 236
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G8 VH-CDR3 peptide

<400> 236
Arg Ala Phe Tyr Ser Gly Phe Pro Thr Gly Tyr 
1               5                   10      


<210> 237
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G8 VL polypeptide

<400> 237
Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Ala Ala Pro Gly Gln 
1               5                   10                  15      


Lys Val Thr Ile Ala Cys Ser Gly Thr Ser Ser Asn Ile Gly Ser Asp 
            20                  25                  30          


Ser Val Ser Trp Phe Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Glu Asn Asn Lys Arg Pro Ser Gly Ile Ser Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Val Thr Leu Gly Ile Thr Gly Leu Gln 
65                  70                  75                  80  


Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Phe Glu Ser Ser Leu 
                85                  90                  95      


Ser Ala Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210> 238
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G8 VL-CDR1 peptide

<400> 238
Ser Ser Asn Ile Gly Ser Asp Ser 
1               5               


<210> 239
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G8 VL-CDR2 peptide

<400> 239
Glu Asn Asn 
1           


<210> 240
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G8 VL-CDR3 peptide

<400> 240
Ala Thr Phe Glu Ser Ser Leu Ser Ala Tyr Val 
1               5                   10      


<210> 241
<211> 360
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G8 VH polynucleotide

<400> 241
caggtacagc ttgtagaaag tgggggtggg cttgtcaagc ctgggggaag tttgagactg       60

agttgcgccg caagtggctt cacgtttaag aacgcatgga tgtcctggat tagacaagcc      120

cccggtaaag gtttggaatg ggtaggacga gttaagtctg aggttgacgc cgggacgata      180

gattacggtg ttcccgtgcg cggcagattc acgataagtc gagacgactc taagaataca      240

ctttacctcc agatgaatag cctcaaaacc gaggatacag ccgtttatta ttgccgcgca      300

ttctatagtg gcttcccgac tgggtactgg gggcaaggta ctcttgtcac agtgtcatcc      360


<210> 242
<211> 330
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G8 VL polynucleotide

<400> 242
cagtccgttt tgacgcaacc cccgtcagtg agtgctgcgc ctgggcagaa ggtgacgatc       60

gcctgctcag ggaccagcag taatataggc tctgattctg tatcatggtt ccagcaactg      120

cctggcacgg cacctaaact gctgatctac gaaaataata agcggccctc aggcatttca      180

gataggttct ctgggagcaa gagtggtaca agcgtaacgc tcggtatcac cggtctccag      240

acaggtgatg aagctgatta ctactgcgct acttttgaga gctctctttc agcttacgtg      300

tttggtaccg ggaccaaagt gacagtcctc                                       330


<210> 243
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G10 VH polypeptide

<400> 243
Glu Val His Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Lys Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Val Lys Ser Glu Val Asp Ala Gly Thr Ile Asp Tyr Gly Val 
    50                  55                  60                  


Pro Val Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Gln Gly Thr 
65                  70                  75                  80  


Leu Ser Leu Glu Met Asn Ser Leu Lys Asp Asp Asp Thr Gly Val Tyr 
                85                  90                  95      


Tyr Cys Arg Ala Phe Tyr Ser Gly Phe Pro Thr Gly Tyr Trp Gly Gln 
            100                 105                 110         


Gly Ala Leu Val Ser Val Ser Ser 
        115                 120 


<210> 244
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G10 VH-CDR1 peptide

<400> 244
Gly Phe Thr Phe Lys Asn Ala Trp 
1               5               


<210> 245
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G10 VH-CDR2 peptide

<400> 245
Val Lys Ser Glu Val Asp Ala Gly Thr Ile 
1               5                   10  


<210> 246
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G10 VH-CDR3 peptide

<400> 246
Arg Ala Phe Tyr Ser Gly Phe Pro Thr Gly Tyr 
1               5                   10      


<210> 247
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G10 VL polypeptide

<400> 247
Gln Ser Val Leu Thr Gln Pro Pro Ser Leu Ser Ala Ala Pro Gly Gln 
1               5                   10                  15      


Thr Ile Thr Ile Ala Cys Ser Gly Thr Ser Ser Asn Ile Gly Ser Asp 
            20                  25                  30          


Ser Val Ser Trp Phe Gln Gln Phe Pro Gly Thr Ala Pro Arg Val Leu 
        35                  40                  45              


Ile Tyr Glu Asn Asn Lys Arg Pro Ser Gly Ile Ser Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Val Thr Leu Gly Ile Thr Gly Leu Gln 
65                  70                  75                  80  


Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Phe Glu Ser Ser Leu 
                85                  90                  95      


Ser Ala Tyr Val Phe Gly Ser Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210> 248
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G10 VL-CDR1 peptide

<400> 248
Ser Ser Asn Ile Gly Ser Asp Ser 
1               5               


<210> 249
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G10 VL-CDR2 peptide

<400> 249
Glu Asn Asn 
1           


<210> 250
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G10 VL-CDR3 peptide

<400> 250
Ala Thr Phe Glu Ser Ser Leu Ser Ala Tyr Val 
1               5                   10      


<210> 251
<211> 360
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G10 VH polynucleotide

<400> 251
gaggtacacc ttgtagaaag tgggggtggg cttgtcaagc ctgggggaag tttgagactg       60

agttgcgccg caagtggctt cacgtttaag aacgcatgga tgtcctggat tagacaagcc      120

cccggtaaag gtttggaatg ggtaggacga gttaagtctg aggttgacgc ggggacgata      180

gattacggtg ttcccgtgcg cggcagattc acgataagtc gagacgactc tcagggtaca      240

cttagcctcg aaatgaatag cctcaaagac gatgatacag gcgtttatta ttgccgcgca      300

ttctacagtg gcttcccgac tgggtactgg gggcaaggtg ctcttgtctc agtgtcatcc      360


<210> 252
<211> 330
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G10 VL polynucleotide

<400> 252
cagtccgttt tgacgcaacc cccgtcactg agtgctgcgc ctgggcagac cataacgatc       60

gcctgctcag ggaccagcag taatataggc tctgattctg tatcatggtt ccagcaattc      120

cctggcacgg cacctcgcgt actgatctac gaaaataata agcggccctc aggcatttca      180

gataggttct ctgggagcaa gagtggtaca agcgtaacgc tcggtatcac cggtctccag      240

acaggtgatg aagctgatta ctactgcgct acttttgaga gctctctttc agcttacgtg      300

tttggttccg ggaccaaagt gacagtcctc                                       330


<210> 253
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G11 VH polypeptide

<400> 253
Glu Val His Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Lys Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Val Lys Ser Glu Val Asp Ala Gly Thr Ile Asp Tyr Gly Val 
    50                  55                  60                  


Pro Val Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Gln Gly Thr 
65                  70                  75                  80  


Leu Ser Leu Glu Met Asn Ser Leu Lys Asp Asp Asp Thr Gly Val Tyr 
                85                  90                  95      


Tyr Cys Arg Ala Phe Tyr Ser Gly Phe Pro Thr Gly Tyr Trp Gly Gln 
            100                 105                 110         


Gly Ala Leu Val Ser Val Ser Ser 
        115                 120 


<210> 254
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G11 VH-CDR1 peptide

<400> 254
Gly Phe Thr Phe Lys Asn Ala Trp 
1               5               


<210> 255
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G11 VH-CDR2 peptide

<400> 255
Val Lys Ser Glu Val Asp Ala Gly Thr Ile 
1               5                   10  


<210> 256
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G11 VH-CDR3 peptide

<400> 256
Arg Ala Phe Tyr Ser Gly Phe Pro Thr Gly Tyr 
1               5                   10      


<210> 257
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G11 VL polypeptide

<400> 257
Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Ala Ala Pro Gly Gln 
1               5                   10                  15      


Lys Val Thr Ile Ala Cys Ser Gly Thr Ser Ser Asn Ile Gly Ser Asp 
            20                  25                  30          


Ser Val Ser Trp Phe Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Glu Asn Asn Lys Arg Pro Ser Gly Ile Ser Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Val Thr Leu Gly Ile Thr Gly Leu Gln 
65                  70                  75                  80  


Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Phe Glu Ser Ser Leu 
                85                  90                  95      


Ser Ala Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210> 258
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G11 VL-CDR1 peptide

<400> 258
Ser Ser Asn Ile Gly Ser Asp Ser 
1               5               


<210> 259
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G11 VL-CDR2 peptide

<400> 259
Glu Asn Asn 
1           


<210> 260
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G11 VL-CDR3 peptide

<400> 260
Ala Thr Phe Glu Ser Ser Leu Ser Ala Tyr Val 
1               5                   10      


<210> 261
<211> 360
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G11 VH polynucleotide

<400> 261
gaggtacacc ttgtagaaag tgggggtggg cttgtcaagc ctgggggaag tttgagactg       60

agttgcgccg caagtggctt cacgtttaag aacgcatgga tgtcctggat tagacaagcc      120

cccggtaaag gtttggaatg ggtaggacga gttaagtctg aggttgacgc ggggacgata      180

gattacggtg ttcccgtgcg cggcagattc acgataagtc gagacgactc tcagggtaca      240

cttagcctcg aaatgaatag cctcaaagac gatgatacag gcgtttatta ttgccgcgca      300

ttctacagtg gcttcccgac tgggtactgg gggcaaggtg ctcttgtctc agtgtcatcc      360


<210> 262
<211> 330
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G11 VL polynucleotide

<400> 262
cagtccgttt tgacgcaacc cccgtcagtg agtgctgcgc ctgggcagaa ggtgacgatc       60

gcctgctcag ggaccagcag taatataggc tctgattctg tatcatggtt ccagcaactg      120

cctggcacgg cacctaaact gctgatctac gaaaataata agcggccctc aggcatttca      180

gataggttct ctgggagcaa gagtggtaca agcgtaacgc tcggtatcac cggtctccag      240

acaggtgatg aagctgatta ctactgcgct acttttgaga gctctctttc agcttacgtg      300

tttggtaccg ggaccaaagt gacagtcctc                                       330


<210> 263
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G14 VH polypeptide

<400> 263
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Lys Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Val Lys Ser Glu Val Asp Ala Gly Thr Ile Asp Tyr Gly Val 
    50                  55                  60                  


Pro Val Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Arg Ala Phe Tyr Ser Gly Phe Pro Thr Gly Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210> 264
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G14 VH-CDR1 peptide

<400> 264
Gly Phe Thr Phe Lys Asn Ala Trp 
1               5               


<210> 265
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G14 VH-CDR2 peptide

<400> 265
Val Lys Ser Glu Val Asp Ala Gly Thr Ile 
1               5                   10  


<210> 266
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G14 VH-CDR3 peptide

<400> 266
Arg Ala Phe Tyr Ser Gly Phe Pro Thr Gly Tyr 
1               5                   10      


<210> 267
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G14 VL polypeptide

<400> 267
Gln Ser Val Leu Thr Gln Pro Pro Ser Leu Ser Ala Ala Pro Gly Gln 
1               5                   10                  15      


Thr Ile Thr Ile Ala Cys Ser Gly Thr Ser Ser Asn Ile Gly Ser Asp 
            20                  25                  30          


Ser Val Ser Trp Phe Gln Gln Phe Pro Gly Thr Ala Pro Arg Val Leu 
        35                  40                  45              


Ile Tyr Glu Asn Asn Lys Arg Pro Ser Gly Ile Ser Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Val Thr Leu Gly Ile Thr Gly Leu Gln 
65                  70                  75                  80  


Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Phe Glu Ser Ser Leu 
                85                  90                  95      


Ser Ala Tyr Val Phe Gly Ser Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210> 268
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G14 VL-CDR1 peptide

<400> 268
Ser Ser Asn Ile Gly Ser Asp Ser 
1               5               


<210> 269
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G14 VL-CDR2 peptide

<400> 269
Glu Asn Asn 
1           


<210> 270
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G14 VL-CDR3 peptide

<400> 270
Ala Thr Phe Glu Ser Ser Leu Ser Ala Tyr Val 
1               5                   10      


<210> 271
<211> 360
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G14 VH polynucleotide

<400> 271
caggtacagc ttgtagaaag tgggggtggg cttgtcaagc ctgggggaag tttgagactg       60

agttgcgccg caagtggctt cacgtttaag aacgcatgga tgtcctggat tagacaagcc      120

cccggtaaag gtttggaatg ggtaggacga gttaagtctg aggttgacgc cgggacgata      180

gattacggtg ttcccgtgcg cggcagattc acgataagtc gagacgactc taagaataca      240

ctttacctcc agatgaatag cctcaaaacc gaggatacag ccgtttatta ttgccgcgca      300

ttctatagtg gcttcccgac tgggtactgg gggcaaggta ctcttgtcac agtgtcatcc      360


<210> 272
<211> 330
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G14 VL polynucleotide

<400> 272
cagtccgttt tgacgcaacc cccgtcactg agtgctgcgc ctgggcagac cataacgatc       60

gcctgctcag ggaccagcag taatataggc tctgattctg tatcatggtt ccagcaattc      120

cctggcacgg cacctcgcgt actgatctac gaaaataata agcggccctc aggcatttca      180

gataggttct ctgggagcaa gagtggtaca agcgtaacgc tcggtatcac cggtctccag      240

acaggtgatg aagctgatta ctactgcgct acttttgaga gctctctttc agcttacgtg      300

tttggttccg ggaccaaagt gacagtcctc                                       330


<210> 273
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G8-HCvFW1 polypeptide

<400> 273
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Lys Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Val Lys Ser Glu Val Asp Ala Gly Thr Ile Asp Tyr Gly Val 
    50                  55                  60                  


Pro Val Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Gln Gly Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Gly Val Tyr 
                85                  90                  95      


Tyr Cys Arg Ala Phe Tyr Ser Gly Phe Pro Thr Gly Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210> 274
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      KPS44-G8-HCvFW2 polypeptide

<400> 274
Gln Val His Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Lys Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Val Lys Ser Glu Val Asp Ala Gly Thr Ile Asp Tyr Gly Val 
    50                  55                  60                  


Pro Val Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Gln Gly Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Gly Val Tyr 
                85                  90                  95      


Tyr Cys Arg Ala Phe Tyr Ser Gly Phe Pro Thr Gly Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


